New hope for kids with severe skin condition in major drug trial

NCT ID NCT06425549

Recruiting now Disease control Sponsor: UCB Biopharma SRL Source: ClinicalTrials.gov ↗

Summary

This study aims to see if a new injectable drug called bimekizumab works better and is as safe as an existing drug, ustekinumab, for children and adolescents with moderate to severe plaque psoriasis. It will involve about 168 participants aged 6 to 18. The main goal is to see how much the skin clears up after 16 weeks of treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Ps0021 20033
RECRUITING

Nagoya, Japan
Ps0021 20071
RECRUITING

Nagasaki, Japan
Ps0021 20337
RECRUITING

Shimotsuga-gun, Japan
Ps0021 40023
ACTIVE_NOT_RECRUITING

Erlangen, Germany
Ps0021 40085
ACTIVE_NOT_RECRUITING

Pisa, Italy
Ps0021 40091
ACTIVE_NOT_RECRUITING

Nowa Sól, Poland
Ps0021 40121
ACTIVE_NOT_RECRUITING

Brussels, Belgium
Ps0021 40138
RECRUITING

Bonn, Germany
Ps0021 40159
RECRUITING

Barcelona, Spain
Ps0021 40177
ACTIVE_NOT_RECRUITING

Münster, Germany
Ps0021 40249
ACTIVE_NOT_RECRUITING

Kiel, Germany
Ps0021 40334
ACTIVE_NOT_RECRUITING

Wroclaw, Poland
Ps0021 40356
ACTIVE_NOT_RECRUITING

Dresden, Germany
Ps0021 40420
RECRUITING

Liège, Belgium
Ps0021 40440
ACTIVE_NOT_RECRUITING

Ancona, Località Torrette, Italy
Ps0021 40515
COMPLETED

Berlin, Germany
Ps0021 40567
ACTIVE_NOT_RECRUITING

Roma, Italy
Ps0021 40625
ACTIVE_NOT_RECRUITING

Warsaw, Poland
Ps0021 40645
ACTIVE_NOT_RECRUITING

Frankfurt am Main, Germany
Ps0021 40737
ACTIVE_NOT_RECRUITING

Rzeszów, Poland
Ps0021 40738
ACTIVE_NOT_RECRUITING

Wroclaw, Poland
Ps0021 40740
ACTIVE_NOT_RECRUITING

Bad Bentheim, Germany
Ps0021 40741
ACTIVE_NOT_RECRUITING

Bialystok, Poland
Ps0021 40742
RECRUITING

Argenteuil, France
Ps0021 40743
ACTIVE_NOT_RECRUITING

Szczecin, Poland
Ps0021 40744
ACTIVE_NOT_RECRUITING

Kaposvár, Hungary
Ps0021 40745
ACTIVE_NOT_RECRUITING

Szeged, Hungary
Ps0021 40746
ACTIVE_NOT_RECRUITING

Debrecen, Hungary
Ps0021 40747
COMPLETED

Mainz, Germany
Ps0021 40748
ACTIVE_NOT_RECRUITING

Plzen-bory, Czechia
Ps0021 40749
ACTIVE_NOT_RECRUITING

Catania, Italy
Ps0021 40750
ACTIVE_NOT_RECRUITING

Alicante, Spain
Ps0021 40751
ACTIVE_NOT_RECRUITING

Esplugues de Llobregat, Spain
Ps0021 40752
ACTIVE_NOT_RECRUITING

Granada, Spain
Ps0021 40753
RECRUITING

Santiago de Compostela, Spain
Ps0021 40754
RECRUITING

Nantes, France
Ps0021 40758
ACTIVE_NOT_RECRUITING

Hamburg, Germany
Ps0021 40832
ACTIVE_NOT_RECRUITING

Lodz, Poland
Ps0021 50084
ACTIVE_NOT_RECRUITING

Charleston, South Carolina, 29425, United States
Ps0021 50161
ACTIVE_NOT_RECRUITING

Los Angeles, California, 90045, United States
Ps0021 50162
ACTIVE_NOT_RECRUITING

Fountain Valley, California, 92708, United States
Ps0021 50196
COMPLETED

Northridge, California, 91325, United States
Ps0021 50201
COMPLETED

Arlington, Texas, 76011, United States
Ps0021 50344
ACTIVE_NOT_RECRUITING

Indianapolis, Indiana, 46250, United States
Ps0021 50355
ACTIVE_NOT_RECRUITING

Dallas, Texas, 75235, United States
Ps0021 50357
ACTIVE_NOT_RECRUITING

St. John's, Canada
Ps0021 50581
RECRUITING

Miami, Florida, 33165, United States
Ps0021 50599
RECRUITING

Kew Gardens, New York, 11415, United States
Ps0021 50617
RECRUITING

St. John's, Canada
Ps0021 50618
ACTIVE_NOT_RECRUITING

Mississauga, Canada

Conditions

Explore the condition pages connected to this study.

MODERATE TO SEVERE PLAQUE PSORIASIS